Mechanisms of resistance to hormonal treatment in breast cancer.
Endocrine therapy is a cornerstone in hormone-dependent breast cancer treatment. Despite the effectiveness of this type of treatment, a significant percentage of tumours develop resistance, and hence, patients relapse. This raises the question of which mechanisms are activated by hormone-dependent tumours to become resistant to antihormonal therapy. The aim of this review is to summarise the current knowledge on structure and mechanisms of action of oestrogen receptors and the possible mechanisms of resistance known to date, focusing on the existing crosstalk between oestrogen receptor and growth factor receptor pathways as well as the influence of drug metabolism in its effectiveness. Finally, the clinical evidence of hormonal therapy resistance and the future directions for optimising breast cancer treatment is also discussed.
Eroles
P
P
Fundación Investigación, Hospital Clínico Universitario de Valencia, Valencia, Spain.
Bosch
A
A
Bermejo
B
B
Lluch
A
A
D000818:Animals; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy / Q000235:genetics*; D019008:Drug Resistance, Neoplasm / Q000235:genetics*; D066246:ErbB Receptors / Q000235:genetics / Q000378:metabolism; D005260:Female; D006801:Humans; D020239:Receptor Cross-Talk / Q000502:physiology; D011960:Receptors, Estrogen / Q000235:genetics / Q000378:metabolism; D015398:Signal Transduction / Q000502:physiology
D018931:Antineoplastic Agents, Hormonal; D011960:Receptors, Estrogen; D066246:ErbB Receptors
Nat Rev Cancer. 2009 Sep;9(9):631-43
19701242
Pharmacogenomics. 2002 Mar;3(2):229-43
11972444
Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9063-8
16754886
Nature. 2005 Dec 15;438(7070):981-7
16355216
J Clin Oncol. 2009 Jun 1;27(16):2630-7
19380449
J Clin Oncol. 2007 Sep 1;25(25):3837-45
17761971
Cell. 1998 Dec 23;95(7):927-37
9875847
Bioessays. 2002 Mar;24(3):244-54
11891761
Breast Cancer Res. 2005;7(3):R284-90
15987423
Breast Cancer Res Treat. 2005 Jun;91(3):249-58
15952058
Clin Cancer Res. 2004 Jan 1;10(1 Pt 2):331S-6S
14734488
Nature. 1986 Mar 13-19;320(6058):134-9
3754034
Lancet. 2005 May 14-20;365(9472):1687-717
15894097
Nature. 2000 Aug 17;406(6797):747-52
10963602
N Engl J Med. 2002 Jan 31;346(5):340-52
11821512
J Clin Invest. 1999 Feb;103(3):401-6
9927501
Biochem Biophys Res Commun. 2009 Mar 13;380(3):699-704
19285025
Biochem Biophys Res Commun. 2005 Nov 4;336(4):1023-7
16165085
J Clin Oncol. 2008 Apr 1;26(10):1603-10
18332469
Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):2920-5
9501191
Oncology. 2008;75(3-4):159-68
18827493
Clin Cancer Res. 2011 Mar 1;17(5):1147-59
21220480
J Clin Oncol. 2009 Nov 20;27(33):5529-37
19786670
Breast Cancer Res Treat. 2008 Jul;110(2):327-35
17851757
Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4429-34
17671126
J Natl Cancer Inst. 2005 Jan 5;97(1):30-9
15632378
J Clin Oncol. 2009 Jul 20;27(21):3423-9
19487384
Endocr Relat Cancer. 2000 Mar;7(1):17-28
10808193
Clin Cancer Res. 2009 Mar 15;15(6):2098-106
19276281
Endocrinology. 1997 Mar;138(3):863-70
9048584
J Biol Chem. 2001 Feb 2;276(5):3459-67
11044445
J Clin Oncol. 2007 Sep 1;25(25):3816-22
17679728
Mol Endocrinol. 1997 Jun;11(6):657-66
9171229
Proc Natl Acad Sci U S A. 1996 Sep 17;93(19):10069-73
8816752
J Clin Oncol. 2001 Sep 15;19(18):3808-16
11559718
Mol Endocrinol. 1997 Jun;11(6):693-705
9171233
J Natl Cancer Inst. 2003 Dec 3;95(23):1758-64
14652237
Clin Cancer Res. 2005 Jan 15;11(2 Pt 2):865s-70s
15701879
Clin Cancer Res. 2003 Apr;9(4):1259-66
12684393
Oncologist. 2001;6(1):4-11
11161223
Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10869-74
11553815
Nature. 2008 Dec 4;456(7222):663-6
19005469
J Endocrinol. 1999 Dec;163(3):379-83
10588810
J Clin Oncol. 2008 Mar 1;26(7):1059-65
18227529
Endocrinology. 1998 Oct;139(10):4252-63
9751507
J Pharmacol Exp Ther. 2004 Sep;310(3):1062-75
15159443
Breast Cancer Res Treat. 2001 Jul;68(1):21-8
11678305
Mol Cell Biol. 2000 Jul;20(14):5041-7
10866661
Breast Cancer Res. 2005;7(5):205-11
16168139
Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):5925-30
8650195
Oncogene. 2002 Jun 6;21(25):4000-8
12037682
Nat Rev Cancer. 2009 Aug;9(8):576-86
19629072
J Natl Cancer Inst. 2004 Jun 16;96(12):926-35
15199112
J Clin Oncol. 2009 Nov 20;27(33):5538-46
19786658
Clin Pharmacol Ther. 2006 Jul;80(1):61-74
16815318
EMBO J. 2000 Sep 1;19(17):4688-700
10970861
Breast Cancer Res. 2007;9(1):R7
17244352
J Clin Oncol. 1996 Oct;14(10):2738-46
8874335
J Biol Chem. 1997 Oct 10;272(41):25832-8
9325313
J Clin Oncol. 2005 Dec 20;23(36):9312-8
16361630